Dec 06, 2019 - Biogen (BIIB) divulges new positive data on Alzheimer's candidate, aducanumab at CTAD. Stock rises.
Dec 06, 2019 - Regeneron (REGN) announces positive top-line data from a phase II study on rare blood disorder drug.
Dec 02, 2019 - Novartis's purchase comes with investigational cardiovascular drug inclisiran, a competitor with potential to dethrone Amgen's already embattled Repatha.
Nov 29, 2019 - Here's why the FDA recently approved five new drugs way ahead of schedule.
Nov 28, 2019 - IMO 2020 sulfur regulation goes into effect January 1, 2020.Frontline has chosen a scrubber strategy.Euronav has chosen a pre-purchase at bulk prices and store compliant fuel.The most economical strat
Nov 27, 2019 - Global Blood's (GBT) Oxbryta wins the FDA nod to address sickle cell disease in patients aged 12 years and above. The approval comes three months ahead of schedule.
Nov 26, 2019 - There’s still a long way to go, but the newcomer is off to a good start.
Nov 26, 2019 - Here are four stocks that boast promising prospects and are most likely to be takeout targets.
Nov 25, 2019 - The FDA accepts Roche's (RHHBY) NDA for risdiplam under a priority review to treat spinal muscular atrophy. A verdict is pending on May 24, 2020.
Nov 25, 2019 - Novartis (NVS) set to acquire The Medicines Company and add a promising candidate to its cardiovascular pipeline.